TIR-domain-containing adapter-inducing interferon-β (TRIF) regulates Th17-mediated intestinal immunopathology in colitis.

TIR-domain-containing adapter-inducing interferon-β (TRIF) regulates Th17-mediated intestinal immunopathology in colitis.
复制标题

DOI:
10.1038/mi.2014.67
复制
发表时间:
2015-03
期刊:
影响因子:
8
通讯作者:
--
中科院分区:
医学1区
文献类型:
--
作者:

文献摘要

参考文献

相似文献

Gastrointestinal mucosa reserves abundant Th17 cells where host response to commensal bacteria maintains Th17-cell generation. Although functional heterogeneity and dynamic plasticity of Th17 cells appear to be involved in chronic inflammatory disorders, how their plasticity is regulated in intestinal mucosa is unknown. Here we show that innate TRIF signaling regulates intestinal Th17-cell generation and plasticity during colitis. Absence of TRIF in mice resulted in increased severity of experimental colitis, which was associated with aberrant generation of Th17 cells especially of interferon (IFN)-γ-expressing Th17 cells in the lamina propria. The abnormal generation and plasticity of Th17 cells involved impaired expression of interleukin (IL)-27p28 by lamina propria macrophages but not dendritic cells. Treatment of TRIF-deficient mice with IL-27p28 during colitis reduced the number and IFN-γ expression of Th17 cells in the intestine. In vitro, TRIF-deficient macrophages induced more Th17 cells than wild-type (WT) macrophages during co-culture with WT naive T cells in response to cecal bacterial antigen. Many of Th17 cells induced by TRIF-deficient macrophages expressed IFN-γ due to impaired expression of IL-27p28 by macrophages and defective activation of STAT1 in T cells. These results outline TRIF-dependent regulatory mechanism by which host response to intestinal bacteria maintains Th17-cell-mediated pathology during colitis.
DOI: 10.1038/ng.489
发表时间: 2009-12
期刊: NATURE GENETICS
影响因子: 30.8
作者:
Imielinski, Marcin;Baldassano, Robert N.;Griffiths, Anne;Russell, Richard K.;Annese, Vito;Dubinsky, Marla;Kugathasan, Subra;Bradfield, Jonathan P.;Walters, Thomas D.;Sleiman, Patrick;Kim, Cecilia E.;Muise, Aleixo;Wang, Kai;Glessner, Joseph T.;Saeed, Shehzad;Zhang, Haitao;Frackelton, Edward C.;Hou, Cuiping;Flory, James H.;Otieno, George;Chiavacci, Rosetta M.;Grundmeier, Robert;Castro, Massimo;Latiano, Anna;Dallapiccola, Bruno;Stempak, Joanne;Abrams, Debra J.;Taylor, Kent;McGovern, Dermot;Heyman, Melvin B.;Ferry, George D.;Kirschner, Barbara;Lee, Jessica;Essers, Jonah;Grand, Richard;Stephens, Michael;Levine, Arie;Piccoli, David;Van Limbergen, Johan;Cucchiara, Salvatore;Monos, Dimitri S.;Guthery, Stephen L.;Denson, Lee;Wilson, David C.;Grant, Struan F. A.;Daly, Mark;Silverberg, Mark S.;Satsangi, Jack;Hakonarson, Hakon
通讯作者: Hakonarson, Hakon
DOI: 10.1172/jci200317464
发表时间: 2003-09-01
影响因子: 15.9
作者:
Becker, C;Wirtz, S;Neurath, MF
通讯作者: Neurath, MF
DOI: 10.4049/jimmunol.0801162
发表时间: 2009-05-01
影响因子: 4.4
作者:
Diveu, Caroline;McGeachy, Mandy J.;Kastelein, Robert A.
通讯作者: Kastelein, Robert A.
DOI: 10.1016/j.jaci.2009.04.003
发表时间: 2009-05-01
影响因子: 14.2
作者:
Louten, Jennifer;Boniface, Katia;Malefyt, Rene de Waal
通讯作者: Malefyt, Rene de Waal
DOI: 10.1136/gutjnl-2011-301668
发表时间: 2012-12
期刊: Gut
影响因子: 24.5
作者:
Hueber W;Sands BE;Lewitzky S;Vandemeulebroecke M;Reinisch W;Higgins PD;Wehkamp J;Feagan BG;Yao MD;Karczewski M;Karczewski J;Pezous N;Bek S;Bruin G;Mellgard B;Berger C;Londei M;Bertolino AP;Tougas G;Travis SP;Secukinumab in Crohn's Disease Study Group
通讯作者: Secukinumab in Crohn's Disease Study Group